 | • レポートコード：MRC2Q12-17453 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、体外生命維持技術のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 体外生命維持技術のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 体外生命維持技術の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 体外生命維持技術のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの体外生命維持技術の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の体外生命維持技術の売上および2028年までの予測に焦点を当てています。 体外生命維持技術のグローバル主要企業には、Medtronic、MAQUET Holding、Microport Scientific、Sorin Group、Nipro Medical、Terumo Cardiovascular Systems、MedosMedizintechnik、Getinge、BiVACOR、SynCardia、Jarvik Heart、CARMAT、AbioMedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 体外生命維持技術市場は、タイプとアプリケーションによって区分されます。世界の体外生命維持技術市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 動静脈（VA-ECMO）、静脈-静脈（VV-ECMO） 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 体外生命維持技術製品概要 - タイプ別市場（動静脈（VA-ECMO）、静脈-静脈（VV-ECMO）） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の体外生命維持技術販売量予測2017-2028 - 世界の体外生命維持技術売上予測2017-2028 - 体外生命維持技術の地域別販売量 - 体外生命維持技術の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別体外生命維持技術販売量 - 主要メーカー別体外生命維持技術売上 - 主要メーカー別体外生命維持技術価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（動静脈（VA-ECMO）、静脈-静脈（VV-ECMO）） - 体外生命維持技術のタイプ別販売量 - 体外生命維持技術のタイプ別売上 - 体外生命維持技術のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 体外生命維持技術のアプリケーション別販売量 - 体外生命維持技術のアプリケーション別売上 - 体外生命維持技術のアプリケーション別価格 ・北米市場 - 北米の体外生命維持技術市場規模（タイプ別、アプリケーション別） - 主要国別の体外生命維持技術市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの体外生命維持技術市場規模（タイプ別、アプリケーション別） - 主要国別の体外生命維持技術市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の体外生命維持技術市場規模（タイプ別、アプリケーション別） - 主要国別の体外生命維持技術市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の体外生命維持技術市場規模（タイプ別、アプリケーション別） - 主要国別の体外生命維持技術市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの体外生命維持技術市場規模（タイプ別、アプリケーション別） - 主要国別の体外生命維持技術市場規模（トルコ、サウジアラビア） ・企業情報 Medtronic、MAQUET Holding、Microport Scientific、Sorin Group、Nipro Medical、Terumo Cardiovascular Systems、MedosMedizintechnik、Getinge、BiVACOR、SynCardia、Jarvik Heart、CARMAT、AbioMed ・産業チェーン及び販売チャネル分析 - 体外生命維持技術の産業チェーン分析 - 体外生命維持技術の原材料 - 体外生命維持技術の生産プロセス - 体外生命維持技術の販売及びマーケティング - 体外生命維持技術の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 体外生命維持技術の産業動向 - 体外生命維持技術のマーケットドライバー - 体外生命維持技術の課題 - 体外生命維持技術の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Extracorporeal Life Support Technology estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Extracorporeal Life Support Technology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Extracorporeal Life Support Technology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Extracorporeal Life Support Technology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Extracorporeal Life Support Technology include Medtronic, MAQUET Holding, Microport Scientific, Sorin Group, Nipro Medical, Terumo Cardiovascular Systems, MedosMedizintechnik, Getinge and BiVACOR, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Extracorporeal Life Support Technology companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Extracorporeal Life Support Technology market. Further, it explains the major drivers and regional dynamics of the global Extracorporeal Life Support Technology market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Medtronic
MAQUET Holding
Microport Scientific
Sorin Group
Nipro Medical
Terumo Cardiovascular Systems
MedosMedizintechnik
Getinge
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Extracorporeal Life Support Technology Segment by Type
Arterial-venous (VA-ECMO)
Veno-venous (VV-ECMO)
Extracorporeal Life Support Technology Segment by Application
Hospital
Clinic
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Extracorporeal Life Support Technology market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Extracorporeal Life Support Technology market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Extracorporeal Life Support Technology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Extracorporeal Life Support Technology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Extracorporeal Life Support Technology revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Extracorporeal Life Support Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Extracorporeal Life Support Technology revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, MAQUET Holding, Microport Scientific, Sorin Group, Nipro Medical, Terumo Cardiovascular Systems, MedosMedizintechnik, Getinge and BiVACOR, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Extracorporeal Life Support Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracorporeal Life Support Technology companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Extracorporeal Life Support Technology revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracorporeal Life Support Technology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Arterial-venous (VA-ECMO)
1.2.3 Veno-venous (VV-ECMO)
1.3 Market by Application
1.3.1 Global Extracorporeal Life Support Technology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Extracorporeal Life Support Technology Market Perspective (2017-2028)
2.2 Extracorporeal Life Support Technology Growth Trends by Region
2.2.1 Extracorporeal Life Support Technology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Extracorporeal Life Support Technology Historic Market Size by Region (2017-2022)
2.2.3 Extracorporeal Life Support Technology Forecasted Market Size by Region (2023-2028)
2.3 Extracorporeal Life Support Technology Market Dynamics
2.3.1 Extracorporeal Life Support Technology Industry Trends
2.3.2 Extracorporeal Life Support Technology Market Drivers
2.3.3 Extracorporeal Life Support Technology Market Challenges
2.3.4 Extracorporeal Life Support Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracorporeal Life Support Technology Players by Revenue
3.1.1 Global Top Extracorporeal Life Support Technology Players by Revenue (2017-2022)
3.1.2 Global Extracorporeal Life Support Technology Revenue Market Share by Players (2017-2022)
3.2 Global Extracorporeal Life Support Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Extracorporeal Life Support Technology Revenue
3.4 Global Extracorporeal Life Support Technology Market Concentration Ratio
3.4.1 Global Extracorporeal Life Support Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracorporeal Life Support Technology Revenue in 2021
3.5 Extracorporeal Life Support Technology Key Players Head office and Area Served
3.6 Key Players Extracorporeal Life Support Technology Product Solution and Service
3.7 Date of Enter into Extracorporeal Life Support Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extracorporeal Life Support Technology Breakdown Data by Type
4.1 Global Extracorporeal Life Support Technology Historic Market Size by Type (2017-2022)
4.2 Global Extracorporeal Life Support Technology Forecasted Market Size by Type (2023-2028)
5 Extracorporeal Life Support Technology Breakdown Data by Application
5.1 Global Extracorporeal Life Support Technology Historic Market Size by Application (2017-2022)
5.2 Global Extracorporeal Life Support Technology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Extracorporeal Life Support Technology Market Size (2017-2028)
6.2 North America Extracorporeal Life Support Technology Market Size by Type
6.2.1 North America Extracorporeal Life Support Technology Market Size by Type (2017-2022)
6.2.2 North America Extracorporeal Life Support Technology Market Size by Type (2023-2028)
6.2.3 North America Extracorporeal Life Support Technology Market Share by Type (2017-2028)
6.3 North America Extracorporeal Life Support Technology Market Size by Application
6.3.1 North America Extracorporeal Life Support Technology Market Size by Application (2017-2022)
6.3.2 North America Extracorporeal Life Support Technology Market Size by Application (2023-2028)
6.3.3 North America Extracorporeal Life Support Technology Market Share by Application (2017-2028)
6.4 North America Extracorporeal Life Support Technology Market Size by Country
6.4.1 North America Extracorporeal Life Support Technology Market Size by Country (2017-2022)
6.4.2 North America Extracorporeal Life Support Technology Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Extracorporeal Life Support Technology Market Size (2017-2028)
7.2 Europe Extracorporeal Life Support Technology Market Size by Type
7.2.1 Europe Extracorporeal Life Support Technology Market Size by Type (2017-2022)
7.2.2 Europe Extracorporeal Life Support Technology Market Size by Type (2023-2028)
7.2.3 Europe Extracorporeal Life Support Technology Market Share by Type (2017-2028)
7.3 Europe Extracorporeal Life Support Technology Market Size by Application
7.3.1 Europe Extracorporeal Life Support Technology Market Size by Application (2017-2022)
7.3.2 Europe Extracorporeal Life Support Technology Market Size by Application (2023-2028)
7.3.3 Europe Extracorporeal Life Support Technology Market Share by Application (2017-2028)
7.4 Europe Extracorporeal Life Support Technology Market Size by Country
7.4.1 Europe Extracorporeal Life Support Technology Market Size by Country (2017-2022)
7.4.2 Europe Extracorporeal Life Support Technology Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extracorporeal Life Support Technology Market Size (2017-2028)
8.2 Asia-Pacific Extracorporeal Life Support Technology Market Size by Type
8.2.1 Asia-Pacific Extracorporeal Life Support Technology Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Extracorporeal Life Support Technology Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Extracorporeal Life Support Technology Market Share by Type (2017-2028)
8.3 Asia-Pacific Extracorporeal Life Support Technology Market Size by Application
8.3.1 Asia-Pacific Extracorporeal Life Support Technology Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Extracorporeal Life Support Technology Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Extracorporeal Life Support Technology Market Share by Application (2017-2028)
8.4 Asia-Pacific Extracorporeal Life Support Technology Market Size by Region
8.4.1 Asia-Pacific Extracorporeal Life Support Technology Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Extracorporeal Life Support Technology Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Extracorporeal Life Support Technology Market Size (2017-2028)
9.2 Latin America Extracorporeal Life Support Technology Market Size by Type
9.2.1 Latin America Extracorporeal Life Support Technology Market Size by Type (2017-2022)
9.2.2 Latin America Extracorporeal Life Support Technology Market Size by Type (2023-2028)
9.2.3 Latin America Extracorporeal Life Support Technology Market Share by Type (2017-2028)
9.3 Latin America Extracorporeal Life Support Technology Market Size by Application
9.3.1 Latin America Extracorporeal Life Support Technology Market Size by Application (2017-2022)
9.3.2 Latin America Extracorporeal Life Support Technology Market Size by Application (2023-2028)
9.3.3 Latin America Extracorporeal Life Support Technology Market Share by Application (2017-2028)
9.4 Latin America Extracorporeal Life Support Technology Market Size by Country
9.4.1 Latin America Extracorporeal Life Support Technology Market Size by Country (2017-2022)
9.4.2 Latin America Extracorporeal Life Support Technology Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracorporeal Life Support Technology Market Size (2017-2028)
10.2 Middle East & Africa Extracorporeal Life Support Technology Market Size by Type
10.2.1 Middle East & Africa Extracorporeal Life Support Technology Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Extracorporeal Life Support Technology Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Extracorporeal Life Support Technology Market Share by Type (2017-2028)
10.3 Middle East & Africa Extracorporeal Life Support Technology Market Size by Application
10.3.1 Middle East & Africa Extracorporeal Life Support Technology Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Extracorporeal Life Support Technology Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Extracorporeal Life Support Technology Market Share by Application (2017-2028)
10.4 Middle East & Africa Extracorporeal Life Support Technology Market Size by Country
10.4.1 Middle East & Africa Extracorporeal Life Support Technology Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Extracorporeal Life Support Technology Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Extracorporeal Life Support Technology Introduction
11.1.4 Medtronic Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.1.5 Medtronic Recent Developments
11.2 MAQUET Holding
11.2.1 MAQUET Holding Company Details
11.2.2 MAQUET Holding Business Overview
11.2.3 MAQUET Holding Extracorporeal Life Support Technology Introduction
11.2.4 MAQUET Holding Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.2.5 MAQUET Holding Recent Developments
11.3 Microport Scientific
11.3.1 Microport Scientific Company Details
11.3.2 Microport Scientific Business Overview
11.3.3 Microport Scientific Extracorporeal Life Support Technology Introduction
11.3.4 Microport Scientific Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.3.5 Microport Scientific Recent Developments
11.4 Sorin Group
11.4.1 Sorin Group Company Details
11.4.2 Sorin Group Business Overview
11.4.3 Sorin Group Extracorporeal Life Support Technology Introduction
11.4.4 Sorin Group Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.4.5 Sorin Group Recent Developments
11.5 Nipro Medical
11.5.1 Nipro Medical Company Details
11.5.2 Nipro Medical Business Overview
11.5.3 Nipro Medical Extracorporeal Life Support Technology Introduction
11.5.4 Nipro Medical Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.5.5 Nipro Medical Recent Developments
11.6 Terumo Cardiovascular Systems
11.6.1 Terumo Cardiovascular Systems Company Details
11.6.2 Terumo Cardiovascular Systems Business Overview
11.6.3 Terumo Cardiovascular Systems Extracorporeal Life Support Technology Introduction
11.6.4 Terumo Cardiovascular Systems Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.6.5 Terumo Cardiovascular Systems Recent Developments
11.7 MedosMedizintechnik
11.7.1 MedosMedizintechnik Company Details
11.7.2 MedosMedizintechnik Business Overview
11.7.3 MedosMedizintechnik Extracorporeal Life Support Technology Introduction
11.7.4 MedosMedizintechnik Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.7.5 MedosMedizintechnik Recent Developments
11.8 Getinge
11.8.1 Getinge Company Details
11.8.2 Getinge Business Overview
11.8.3 Getinge Extracorporeal Life Support Technology Introduction
11.8.4 Getinge Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.8.5 Getinge Recent Developments
11.9 BiVACOR
11.9.1 BiVACOR Company Details
11.9.2 BiVACOR Business Overview
11.9.3 BiVACOR Extracorporeal Life Support Technology Introduction
11.9.4 BiVACOR Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.9.5 BiVACOR Recent Developments
11.10 SynCardia
11.10.1 SynCardia Company Details
11.10.2 SynCardia Business Overview
11.10.3 SynCardia Extracorporeal Life Support Technology Introduction
11.10.4 SynCardia Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.10.5 SynCardia Recent Developments
11.11 Jarvik Heart
11.11.1 Jarvik Heart Company Details
11.11.2 Jarvik Heart Business Overview
11.11.3 Jarvik Heart Extracorporeal Life Support Technology Introduction
11.11.4 Jarvik Heart Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.11.5 Jarvik Heart Recent Developments
11.12 CARMAT
11.12.1 CARMAT Company Details
11.12.2 CARMAT Business Overview
11.12.3 CARMAT Extracorporeal Life Support Technology Introduction
11.12.4 CARMAT Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.12.5 CARMAT Recent Developments
11.13 AbioMed
11.13.1 AbioMed Company Details
11.13.2 AbioMed Business Overview
11.13.3 AbioMed Extracorporeal Life Support Technology Introduction
11.13.4 AbioMed Revenue in Extracorporeal Life Support Technology Business (2017-2022)
11.13.5 AbioMed Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer